ProKidney
PROK
74 hedge funds and large institutions have $86.1M invested in ProKidney in 2024 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 17 reducing their positions, and 12 closing their positions.
76% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 17
25% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 12
4% more funds holding
Funds holding: 71 → 74 (+3)
0.8% more ownership
Funds ownership: 38.99% → 39.79% (+0.8%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less capital invested
Capital invested by funds: $94.3M → $86.1M (-$8.28M)
69% less call options, than puts
Call options by funds: $9K | Put options by funds: $29K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HWAM
Hennion & Walsh Asset Management
Parsippany,
New Jersey
|
+$1.03M |
| 2 |
BlackRock
New York
|
+$583K |
| 3 |
State Street
Boston,
Massachusetts
|
+$558K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$373K |
| 5 |
BL
Bleichroeder LP
New York
|
+$279K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$535K |
| 2 |
MIM
MetLife Investment Management
Whippany,
New Jersey
|
-$98.7K |
| 3 |
Jane Street
New York
|
-$77.8K |
| 4 |
D.E. Shaw & Co
New York
|
-$77.4K |
| 5 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
-$64.9K |
PROK Hedge Fund Activity: Q4 2024 in Review
74 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in ProKidney (PROK) for Q4 2024, worth a combined $86.1M — down 8.8% from $94.3M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new PROK positions and 12 closed out — a net gain of 3 holders — while 30 added to existing stakes and 17 trimmed.
The largest buyer was Hennion & Walsh Asset Management, opening a new position worth an estimated $1.03M. The largest seller was Morgan Stanley, cutting an estimated $535K.
- 74 institutional investors held ProKidney (PROK) as of Q4 2024, up from 71 in Q3 2024.
- Funds reported $86.1M of ProKidney stock for Q4 2024, down 8.8% quarter-over-quarter.
- 15 funds opened new ProKidney positions in Q4 2024 and 12 closed out, a net change of +3 holders.
- The largest ProKidney buyer in Q4 2024 was Hennion & Walsh Asset Management, an estimated $1.03M added.
- The largest ProKidney seller in Q4 2024 was Morgan Stanley, an estimated $535K sold.
Based on aggregated 13F filings for Q4 2024.